Is intravenous thrombolysis feasible in a developing country?

Cerebrovascular Diseases

Volumn 20, Issue 2, 2005, Pages 134-136

  Pandian, Jeyaraj Durai ^a,b   Sethi, Vineeta ^a   Dhillon, Robinderjeet ^a   Kaur, Ravneet ^a   Padala, Smita ^a   Chakravorty, Rajesh ^a   Singh, Yashpal ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONVALESCENCE; DEVELOPING COUNTRY; FEASIBILITY STUDY; FIBRINOLYTIC THERAPY; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; DEVELOPING COUNTRIES; ETHNIC GROUPS; HUMANS; MIDDLE AGED; PLASMINOGEN ACTIVATORS; RECOMBINANT PROTEINS; SEX FACTORS; SOCIOECONOMIC FACTORS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 23844503386     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086804     Document Type: Article

References (10)

1. Grotta JC, Burgin WS, El-Mitwalli A, Long M, Campbell M, Morgenstern LB, Malkoff M, Alexandrov AV: Intravenous tissue-type plasminogen activator for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 2001;58:2009-2013.
2. Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM: Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke 2003;34:799-800.
3. Grond M, Stenzel C, Schmulling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss WD: Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998;29:1544-1549.
4. Nandigam K, Narayan SK, Elangovan S, Dutta TK, Sethuraman KR, Das AK: Feasibility of acute thrombolytic therapy for stroke. Neurol India 2003;51:470-473.
5. Census of India: census data online. 2004. http://www.censusindia.net.
6. Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason C, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W: Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1996;27:1711-1718.
7. Koennecke HC, Nohr R, Leistner S, Marx P: Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-centre, 2-year experience. Stroke 2001;32:1074-1078.
8. Buchan AM, Barber PA, Newcommon N, Karbalai HG, Demchuk AM, Hoyte KM, Klein GM, Feasby TE: Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness. Stroke 2000;54:679-688.
9. Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, Yatsu FM, Grotta JC: Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18-22.
10. Chapman KM, Woolfenden AR, Graeb D, Johnston DC, Beckman J, Schulzer M, Teal PA: Intravenous tissue plasminogen activator for acute ischemic stroke: a Canadian hospital's experience. Stroke 2000;31:2920-2924.